Suggestions
Helen Hsu
Sr. Medical Director Clinical Development at Epizyme
Helen Hsu is a prominent figure in the pharmaceutical industry, currently serving as the Senior Medical Director of Clinical Development at Epizyme, a company specializing in innovative cancer therapies. She holds an MD and MS, reflecting her extensive educational background and expertise in medicine and clinical development.
With over 20 years of experience, Hsu has established a successful track record in various roles within the healthcare sector. Her professional journey includes significant positions where she has contributed to clinical development and strategy in oncology and hematology. Prior to her role at Epizyme, she worked as a Senior Medical Director and Clinical Development Consultant, demonstrating her versatility and leadership in the field.234
Hsu's work primarily focuses on developing therapies that target specific genetic mutations associated with cancer, particularly through epigenetic mechanisms. Her involvement in clinical trials and drug development positions her as a key player in advancing treatment options for patients with malignancies.1
In addition to her professional accomplishments, Hsu is recognized for her strategic insights into the pharmaceutical landscape, making her a valuable asset to any organization she collaborates with.
